What are CVS Health's total assets?

CVS Health (CVS) holds $252.97B in total assets, down 1.0% year over year.

How much debt does CVS Health have?

CVS Health carries $15.2B in total debt against $77.5B of shareholders' equity, a debt-to-equity ratio of 0.20.

How much cash does CVS Health have?

CVS Health holds $9.8B in cash and equivalents.

Can CVS Health cover its short-term obligations?

Its current ratio is 0.87 — current liabilities exceed current assets.

Where does CVS Health's balance sheet data come from?

Every line is extracted from CVS Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

CVS Health CVS Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$9.77B-5.6%	$8.71B-1.9%	$9.35B+31.0%	$12.03B-6.2%	$10.35B+2.4%
Restricted cash	$14M-78.5%	$59M-37.9%	$57M-12.3%	$43M-20.4%	$65M+27.5%
Accounts receivable, net	$40.99B+3.4%	$39.78B+9.1%	$43.86B+21.2%	$40.65B+25.5%	$39.63B+23.0%
Inventories	$17.77B+2.2%	$19.25B+6.3%	$18.96B+7.4%	$17.45B+8.6%	$17.39B+6.4%
Contract assets	$12.51B+19.7%	$10.56B+6.9%	$11.22B+13.5%	$10.47B+6.9%	$10.45B-1.3%
Premiums receivable	$7.63B+22.9%	$5.75B+21.6%	$4.88B+23.7%	$5.89B+32.8%	$6.21B+14.6%
Total current assets	$74.82B+2.2%	$74.71B+8.8%	$77.11B+14.5%	$75.65B+8.1%	$73.19B+8.5%
Goodwill	$85.48B-6.3%	$85.48B-6.3%	$85.48B-6.3%	$91.2B-0.1%	$91.2B-0.1%
Equity securities	——	——	——	——	——
Total assets	$252.97B-1.0%	$253.54B+0.1%	$255.33B+1.1%	$258.34B+2.3%	$255.59B+2.3%
Accounts payable	$16.92B+2.3%	$17.64B+11.0%	$17.76B+13.1%	$17.26B+19.7%	$16.53B+20.5%
Operating lease liabilities, current	$1.9B-0.3%	$1.74B-0.8%	$1.91B-0.2%	$1.91B-0.3%	$1.91B+0.2%
Total current liabilities	$86.41B-2.9%	$88.69B+4.8%	$92.7B+9.5%	$94.16B+15.7%	$88.96B+6.8%
Operating lease liabilities, non-current	$13.33B-8.7%	$13.64B-8.4%	$14.01B-8.2%	$14.33B-7.8%	$14.59B-7.3%
Other non-current liabilities	$6.71B+23.8%	$6.77B+24.7%	$4.76B-13.2%	$4.78B-13.5%	$5.42B-12.7%
Total liabilities	$175.34B-1.8%	$178.16B+0.4%	$182.22B+2.8%	$180.79B+1.9%	$178.48B+1.6%
Retained earnings	$63.28B-0.8%	$61.2B-2.6%	$59.11B-4.7%	$63.94B+1.8%	$63.77B+3.1%
Accumulated other comprehensive income (loss)	$201M+241%	$406M+438%	$416M+99.0%	$272M+185%	$59M+117%
Treasury stock	$36.71B-0.1%	$36.79B-0.1%	$36.78B-0.1%	$36.85B-0.2%	$36.74B-0.1%
Total stockholders' equity	$77.46B+0.7%	$75.21B-0.5%	$72.93B-2.7%	$77.38B+3.3%	$76.93B+4.0%
Total liabilities and stockholders' equity	$252.97B-1.0%	$253.54B+0.1%	$255.33B+1.1%	$258.34B+2.3%	$255.59B+2.3%
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)	——	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)	$2.74B-45.6%	$3.48B-39.4%	$3.66B-44.4%	$4.14B-53.8%	$5.04B-47.9%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$10.08B+107%	$2.86B-62.0%	$1.78B+104%	$2.51B-58.5%	$4.87B+6.3%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value	$2.74B-45.6%	$3.48B-39.4%	$3.66B-44.4%	$4.14B-53.8%	$5.04B-47.9%
AFS and Trading Securities - Unrealized Loss Position Fair Value	$12.82B+29.5%	$6.33B-52.2%	$5.44B-27.0%	$6.65B-55.7%	$9.9B-30.5%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$10.08B+107%	$2.86B-62.0%	$1.78B+104%	$2.51B-58.5%	$4.87B+6.3%
Allowance for Doubtful Accounts	$200M-49.0%	$182M-55.3%	$178M-48.6%	$374M+5.4%	$392M-2.5%
Other current assets	$4.25B+20.6%	$5.09B+65.5%	$3.06B-20.3%	$3.38B-35.5%	$3.53B-39.4%
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)	$6.7B-23.5%	$7.9B-0.8%	$9.98B+48.2%	$9.05B+95.4%	$8.76B+148%
Deferred Tax Assets and Other Non-Current Assets	$7.42B+41.9%	$7.11B+48.4%	$5.16B+8.3%	$5.21B+8.7%	$5.23B+9.0%
Other intangible assets—net	$25.07B-5.6%	$25.51B-6.6%	$25.98B-6.6%	$26.22B-7.4%	$26.57B-7.6%
Investments	$34.67B+10.1%	$34.81B+11.1%	$33.69B+6.1%	$32.24B+12.0%	$31.48B+15.1%
Investments	$32.41B+12.1%	$32.67B+12.9%	$31.55B+9.0%	$29.86B+19.3%	$28.91B+20.1%
Operating lease right-of-use assets	$14.74B-6.1%	$14.97B-6.1%	$15.27B-5.9%	$15.51B-8.2%	$15.7B-7.9%
Other non-current assets	$7.42B+41.9%	$7.11B+48.4%	$5.16B+8.3%	$5.21B+8.7%	$5.23B+9.0%
Property, plant and equipment, net	$13.04B+1.4%	$13.08B+0.7%	$12.84B+0.9%	$12.83B—	$12.86B—
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$2.26B-12.3%	$2.15B-10.9%	$2.13B-23.9%	$2.39B-36.5%	$2.58B-21.6%
Operating Lease Right-of-Use Assets in Other Assets	$14.74B-6.1%	$14.97B-6.1%	$15.27B-5.9%	$15.51B-8.2%	$15.7B-7.9%
Software and Technology Licenses, Net	$7.42B+41.9%	$7.11B+48.4%	$5.16B+8.3%	$5.21B+8.7%	$5.23B+9.0%
Other Commercial Liabilities	$22.26B-0.5%	$22.39B+7.6%	$23.42B+16.1%	$23.1B+9.2%	$22.37B+0.1%
Accrued Liabilities, Current	$22.26B-0.5%	$22.39B+7.6%	$23.42B+16.1%	$23.1B+9.2%	$22.37B+0.1%
Current Portion of Long-Term Debt and Finance Lease Obligations	$2.58B-41.5%	$4.07B+12.3%	$4.08B-16.9%	$6.16B+65.1%	$4.41B+18.2%
Long-Term Debt and Finance Lease Obligations	$60.53B+2.5%	$60.5B0.0%	$60.51B+1.1%	$57.29B-8.5%	$59.04B+2.3%
Liability For Claims And Claims Adjustment Expense And Health Care Organization, Accounts Payable To Third-Party Payor	$15.52B+2.7%	$15.4B+2.2%	$16.1B+5.7%	$15.27B+10.0%	$15.11B+5.2%
Other insurance liabilities	$1.08B-31.5%	$1.12B-5.7%	$1.1B+4.3%	$1.09B+4.5%	$1.57B+35.6%
Other long-term insurance liabilities	$4.59B-5.8%	$4.72B-3.8%	$4.77B-7.7%	$4.77B-5.4%	$4.87B-5.9%
Pharmacy claims and discounts payable	$26.15B+1.4%	$26.34B+9.0%	$27.09B+13.2%	$26.34B+8.9%	$25.8B+15.7%
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss	$305M-35.9%	$301M-48.1%	$307M-31.2%	$396M-50.4%	$476M-42.4%
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Accumulated Loss	5.3K+74.9%	1.6K-64.9%	1.1K+125%	1.5K-56.3%	3K+14.3%
Common stock	$50.68B+1.7%	$50.4B+1.5%	$50.18B+1.4%	$50.02B+1.3%	$49.84B+1.3%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Investments - Gross Unrealized Losses	$12.82B+29.5%	$6.33B-52.2%	$5.44B-27.0%	$6.65B-55.7%	$9.9B-30.5%
Accounts Receivable, Allowance for Credit Loss	$200M-49.0%	$182M-55.3%	$178M-48.6%	$374M+5.4%	$392M-2.5%
Effect of changes in discount rate assumptions	$18M+1,000%	$20M+1,900%	$24M+26.3%	$30M+25.0%	-$2M-109%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$447M-18.3%	$331M-53.2%	$332M-26.7%	$449M-48.0%	$547M-37.3%
Gross Unrealized Gains	$245M-0.4%	$449M+152%	$462M-9.4%	$347M+138%	$246M+28.8%
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10	——	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10	——	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——	——
Available for sale investments	$28.39B+9.0%	$28.72B+10.3%	$27.84B+5.1%	$26.55B+11.4%	$26.04B+15.1%
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	3.2B0.0%	3.2B0.0%	3.2B0.0%	3.2B0.0%	3.2B0.0%
Common stock, shares issued (in shares)	1.8B+0.5%	1.8B+0.5%	1.8B+0.5%	1.8B+0.5%	1.8B+0.5%
Common Stock, Shares, Outstanding	1.3B+0.9%	1.3B+0.9%	1.3B+1.0%	1.3B+0.9%	1.3B+0.8%
Debt Securities, Available-for-Sale, Allowance for Credit Loss	$0—	$0—	$0—	$0—	$0—
Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss	$28.59B+8.5%	$28.6B+7.7%	$27.71B+4.8%	$26.66B+8.6%	$26.35B+13.0%
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	$305M-35.9%	$301M-48.1%	$307M-31.2%	$396M-50.4%	$476M-42.4%
Less than 12 months	$10.08B+107%	$2.86B-62.0%	$1.78B+104%	$2.51B-58.5%	$4.87B+6.3%
12 months or more	$2.74B-45.6%	$3.48B-39.4%	$3.66B-44.4%	$4.14B-53.8%	$5.04B-47.9%
Number of Securities, Greater than 12 months	2K-45.6%	2.5K-40.9%	2.7K-41.3%	3.1K-50.8%	3.7K-43.6%
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	$142M+100%	$30M-76.4%	$25M+257%	$53M-17.2%	$71M+51.1%
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss	$447M-18.3%	$331M-53.2%	$332M-26.7%	$449M-48.0%	$547M-37.3%
Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions	7.3K+8.4%	4K-53.4%	3.8K-25.0%	4.6K-52.8%	6.7K-27.0%
Debt Securities, Available-for-Sale, Unrealized Loss Position	$12.82B+29.5%	$6.33B-52.2%	$5.44B-27.0%	$6.65B-55.7%	$9.9B-30.5%
Deferred income taxes	$3.77B+2.9%	$3.83B+0.7%	$3.55B-2.3%	$3.6B-11.1%	$3.66B-12.4%
Financial Liabilities Fair Value Disclosure	——	——	——	——	——
Guarantor obligations, number of leases	——	——	——	——	——
Gains expected to be reclassified	——	——	——	——	——
Liability for Unpaid Claims and Claims Adjustment Expense, Net	$15.4B+5.8%	$15.33B+2.3%	$15.3B+5.4%	$14.3B+3.2%	$14.57B+1.2%
Less: current maturities	$2.58B-41.5%	$4.07B+12.3%	$4.08B-16.9%	$6.16B+65.1%	$4.41B+18.2%
Noncontrolling interests in subsidiaries	$181M0.0%	$168M-1.2%	$182M+12.3%	$172M-5.0%	$181M-0.5%
Number of pharmacy plan members	——	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Preferred Stock, Shares Authorized	100K0.0%	100K0.0%	100K0.0%	100K0.0%	100K0.0%
Preferred Stock, Shares Issued	0—	0—	0—	0—	0—
Preferred Stock, Shares Outstanding	0—	0—	0—	0—	0—
Premium deficiency reserve	——	——	——	——	——
Reinsurance recoverable on unpaid losses and loss expenses	$132M+15.8%	$90M+11.1%	$94M+44.6%	$103M+74.6%	$114M+2,750%
Incurred but not reported (IBNR) claims liability, net	——	——	——	——	——
Treasury stock, shares (in shares)	515M-0.4%	516M-0.4%	516M-0.6%	518M-0.6%	517M-0.4%
Treasury shares held in trust (in shares)	1M0.0%	1M0.0%	1M0.0%	1M0.0%	1M0.0%
Treasury shares held in trust	$29M0.0%	$29M0.0%	$29M0.0%	$29M0.0%	$29M0.0%
Vendor and manufacturer receivables	$14.14B-0.4%	$15.56B+12.0%	$17.78B+13.8%	$15.25B+12.7%	$14.21B+12.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about CVS Health.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are CVS Health's total assets?: CVS Health (CVS) holds $252.97B in total assets, down 1.0% year over year.
How much debt does CVS Health have?: CVS Health carries $15.2B in total debt against $77.5B of shareholders' equity, a debt-to-equity ratio of 0.20.
How much cash does CVS Health have?: CVS Health holds $9.8B in cash and equivalents.
Can CVS Health cover its short-term obligations?: Its current ratio is 0.87 — current liabilities exceed current assets.
Where does CVS Health's balance sheet data come from?: Every line is extracted from CVS Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.